SARS‐CoV‐2 biology and variants: anticipation of viral evolution and what needs to be done
Open Access
- 26 March 2021
- journal article
- research article
- Published by Wiley in Environmental Microbiology
- Vol. 23 (5), 2339-2363
- https://doi.org/10.1111/1462-2920.15487
Abstract
The global propagation of SARS‐CoV‐2 and the detection of a large number of variants, some of which have replaced the original clade to become dominant, underscores the fact that the virus is actively exploring its evolutionary space. The longer high levels of viral multiplication occur – permitted by high levels of transmission –, the more the virus can adapt to the human host and find ways tosuccess. The third wave of the COVID‐19 pandemic is starting in different parts of the world, emphasizing that transmission containment measures that are being imposed are not adequate. Part of the consideration in determining containment measures is the rationale that vaccination will soon stop transmission and allow a return to normality. However, vaccines themselves represent a selection pressure for evolution of vaccine‐resistant variants, so the coupling of a policy of permitting high levels of transmission/virus multiplication during vaccine roll‐out with the expectation that vaccines will deal with the pandemic, is unrealistic. In the absence of effective antivirals, it is not improbable that SARS‐CoV‐2 infection prophylaxis will involve an annual vaccination campaign against “dominant” viral variants, similar to influenza prophylaxis. Living with COVID‐19 will be an issue of SARS‐CoV‐2 variants and evolution. It is therefore crucial to understand how SARS‐CoV‐2 evolves and what constrains its evolution, in order to anticipate the variants that will emerge. Thus far, the focus has been on the receptor‐binding spike protein, but the virus is complex, encoding 26 proteins which interact with a large number of host factors, so the possibilities for evolution are manifold and not predictable a priori. However, if we are to mount the best defence against COVID‐19, we must mount it against the variants, and to do this, we must have knowledge about the evolutionary possibilities of the virus. In addition to the generic cellular interactions of the virus, there are extensive polymorphisms in humans (e.g. Lewis, HLA, etc.), some distributed within most or all populations, some restricted to specific ethnic populations, and these variations pose additional opportunities for/constraints on viral evolution. We now have the wherewithal – viral genome sequencing, protein structure determination/modelling, protein interaction analysis – to functionally characterise viral variants, but access to comprehensive genome data is extremely uneven. Yet, to develop an understanding of the impacts of such evolution on transmission and disease, we must link it to transmission (viral epidemiology) and disease data (patient clinical data), and the population granularities of these. In this editorial, we explore key facets of viral biology and the influence of relevant aspects of human polymorphisms, human behaviour, geography and climate and, based on this, derive a series of recommendations to monitor viral evolution and predict the types of variants that are likely to arise.Keywords
This publication has 180 references indexed in Scilit:
- Prospects for Emerging Infections in East and Southeast Asia 10 Years after Severe Acute Respiratory SyndromeEmerging Infectious Diseases, 2013
- Viral precursor polyproteins: keys of regulation from replication to maturationCurrent Opinion in Virology, 2013
- T-705 (Favipiravir) Induces Lethal Mutagenesis in Influenza A H1N1 Viruses In VitroJournal of Virology, 2013
- Louis Pasteur, the Father of Immunology?Frontiers in Immunology, 2012
- Cleavage and Activation of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein by Human Airway Trypsin-Like ProteaseJournal of Virology, 2011
- Vectored vaccines to protect against PRRSVVirus Research, 2010
- Adaptive evolution of energy metabolism genes and the origin of flight in batsProceedings of the National Academy of Sciences of the United States of America, 2010
- Proteolytic Activation of the Spike Protein at a Novel RRRR/S Motif Is Implicated in Furin-Dependent Entry, Syncytium Formation, and Infectivity of Coronavirus Infectious Bronchitis Virus in Cultured CellsJournal of Virology, 2009
- RNA under attack: Cellular handling of RNA damageCritical Reviews in Biochemistry and Molecular Biology, 2009
- Proteomics Analysis Unravels the Functional Repertoire of Coronavirus Nonstructural Protein 3Journal of Virology, 2008